BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2025 3:57:04 AM | Browse: 59 | Download: 287
 |
Received |
|
2025-07-31 02:30 |
|
Peer-Review Started |
|
2025-07-31 02:30 |
|
First Decision by Editorial Office Director |
|
2025-08-05 08:42 |
|
Return for Revision |
|
2025-08-05 08:42 |
|
Revised |
|
2025-08-18 05:52 |
|
Publication Fee Transferred |
|
2025-08-23 23:28 |
|
Second Decision by Editor |
|
2025-10-31 10:20 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-03 10:08 |
|
Articles in Press |
|
2025-11-03 10:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-19 01:20 |
|
Publish the Manuscript Online |
|
2025-11-26 03:57 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Orthopedics |
| Manuscript Type |
Basic Study |
| Article Title |
Thymoquinone inhibited the chondrogenic differentiation of tendon-derived stem cells caused by tendon injury
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Jun Tu, Yun-Qi Liu, Yan-Yan Pan, Hong-Yang Cai and Chang Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Department of Science & Technology of Liaoning Province |
2024-MS-285 |
| National Natural Science Foundation of China |
82303572 |
|
| Corresponding Author |
Chang Liu, Affiliate Associate Professor, PhD, /, Central Hospital of Dalian University of Technology, No. 826 Southwest Road, Dalian 116033, Liaoning Province, China. liuch2024@dlut.edu.cn |
| Key Words |
Tendon-derived stem cells; Thymoquinone; Chondrogenic differentiation; Endoplasmic reticulum stress; Tendinopathy |
| Core Tip |
In our previous investigation, we demonstrated that micro-injured tendon with 6.4% strain promoted the chondrogenic differentiation of tendon-derived stem cells, by activating endoplasmic reticulum (ER) stress. To further validate this phenomenon in the animal model, we established a rat Achilles tendon injury model via treadmill running. In the present study, tendon injury was found to activate ER stress by upregulating the protein kinase RNA-like ER kinase/eukaryotic initiation factor 2/activating transcription factor 4/CCAAT/enhancer-binding protein homologous protein pathway, and thymoquinone was shown to alleviate ER stress, while inhibiting the chondrogenic differentiation of tendon-derived stem cells both in vitro and in vivo models. These findings suggested that thymoquinone may hold potential as a preventive and therapeutic agent for tendinopathy. |
| Publish Date |
2025-11-26 03:57 |
| Citation |
Tu YJ, Liu YQ, Pan YY, Cai HY, Liu C. Thymoquinone inhibited the chondrogenic differentiation of tendon-derived stem cells caused by tendon injury. World J Stem Cells 2025; 17(11): 112393 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i11/112393.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i11.112393 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
